glp-1 receptor agonist natural GLP-1_receptor_som_behandling_af_steatotisk_leversygdom Best Med #2: GLP-1 Receptor
Description
doi: 10.17235/reed.2024.10305/2024 106 DesaiAKhataniarHHashashJGFarrayeFARegueiroMKochharGS

Semaglutide is available as a convenient, once-weekly injection

Obesity drug market leaders Novo Nordisk and Eli Lilly are in an intense race, ramping up investments in manufacturing, obesity drug clinical trials, and regulatory approvals to dominate this booming sector

Some workarounds exist
Clinicians make independent determinations based on individual eligibility

Future large-scale randomized trials with extended follow-up and standardized respiratory endpoints are warranted to clarify durability and causal mechanisms
